IMCC (IM Cannabis) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


IMCC IM Cannabis Corp IMCC
36 GF Score
Price $0.14
GF Value $1.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is IM Cannabis Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

IM Cannabis's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


IMCC vs CPMD, SKYI, BSPK: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Margin of Safety % (DCF Earnings Based) falls into.


IMCC
36GF Score
IM Cannabis Corp IMCC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.14 is trading 89.8% below its estimated GF Value™ of $1.39. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $1.39 vs. price of $0.14 (89.8% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score

Get the complete analysis for IMCC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$1.39
GF Value